Silverfin false false 31/03/2025 01/04/2024 31/03/2025 R Masson-Taylor 12/07/2022 30 October 2025 no description of principal activity 14228652 2025-03-31 14228652 bus:Director1 2025-03-31 14228652 2024-03-31 14228652 core:CurrentFinancialInstruments 2025-03-31 14228652 core:CurrentFinancialInstruments 2024-03-31 14228652 core:ShareCapital 2025-03-31 14228652 core:ShareCapital 2024-03-31 14228652 core:RetainedEarningsAccumulatedLosses 2025-03-31 14228652 core:RetainedEarningsAccumulatedLosses 2024-03-31 14228652 core:CostValuation 2024-03-31 14228652 core:CostValuation 2025-03-31 14228652 core:SubsidiariesWithMaterialNon-controllingInterests core:CurrentFinancialInstruments 2025-03-31 14228652 core:SubsidiariesWithMaterialNon-controllingInterests core:CurrentFinancialInstruments 2024-03-31 14228652 2024-04-01 2025-03-31 14228652 bus:FilletedAccounts 2024-04-01 2025-03-31 14228652 bus:SmallEntities 2024-04-01 2025-03-31 14228652 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 14228652 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14228652 bus:Director1 2024-04-01 2025-03-31 14228652 2023-04-01 2024-03-31 14228652 core:CurrentFinancialInstruments 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 14228652 (England and Wales)

MARDAN GROUP LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

MARDAN GROUP LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

MARDAN GROUP LIMITED

BALANCE SHEET

As at 31 March 2025
MARDAN GROUP LIMITED

BALANCE SHEET (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Investments 3 1,027,416 1,027,416
1,027,416 1,027,416
Current assets
Debtors 4 0 71,583
Cash at bank and in hand 4,958 5,000
4,958 76,583
Creditors: amounts falling due within one year 5 ( 739,521) ( 908,844)
Net current liabilities (734,563) (832,261)
Total assets less current liabilities 292,853 195,155
Net assets 292,853 195,155
Capital and reserves
Called-up share capital 100 100
Profit and loss account 292,753 195,055
Total shareholder's funds 292,853 195,155

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Mardan Group Limited (registered number: 14228652) were approved and authorised for issue by the Director on 30 October 2025. They were signed on its behalf by:

R Masson-Taylor
Director
MARDAN GROUP LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
MARDAN GROUP LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Mardan Group Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Maltravers House, Petters Way, Yeovil, BA20 1SH, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

At the balance sheet date the company is in a net current liabilities position but is in a net assets position overall and continues to have the support of the directors and other companies which are under common control. At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including the director 1 1

3. Fixed asset investments

Investments in subsidiaries

2025
£
Cost
At 01 April 2024 1,027,416
At 31 March 2025 1,027,416
Carrying value at 31 March 2025 1,027,416
Carrying value at 31 March 2024 1,027,416

4. Debtors

2025 2024
£ £
Amounts owed by own subsidiaries 0 71,583

5. Creditors: amounts falling due within one year

2025 2024
£ £
Amounts owed to own subsidiaries 30,858 0
Other creditors 708,663 908,844
739,521 908,844

Other creditors represents interest free loans provided by the director.